1. New Onset of Giant Cell Arteritis following ChAdOx1-S (Vaxevria®) Vaccine Administration
- Author
-
Luca Lo Sardo, Simone Parisi, Maria Chiara Ditto, Rosanna De Giovanni, Francesca Maletta, Serena Grimaldi, Luisa Brussino, and Enrico Fusaro
- Subjects
giant cell arteritis ,vaccines ,COVID-19 ,adverse events ,Medicine - Abstract
We report a 78-year-old man presenting with persistent headaches in vertex and temporo-parietal area; fatigue, worsening after walking; jaw claudication; scotomas; pharyngodynia; and dry cough after the second dose of the SARS-CoV-2 vaccine (ChAdOx1-S) administration. Laboratory findings showed an elevated C-reactive protein level and FDG-CT PET showed evidence of active large vessel vasculitis with diffuse abnormal artery uptake. Under suspicion of vasculitis, a temporal arteries biopsy was performed; the histopathologic findings demonstrated the transmural inflammatory infiltrate with giant cells, compatible with giant cell arteritis. Although the overall incidence of vaccine-triggered autoimmunity is low, rheumatologists worldwide should be aware of autoimmune diseases as a new potential adverse event of vaccines.
- Published
- 2023
- Full Text
- View/download PDF